Home › Ewing Sarcoma › Florida
Pag-aaral pangklinika para sa Ewing Sarcoma sa Florida
7 pag-aaral para sa Ewing Sarcoma ang naghahanap ng mga kalahok sa mga site sa Florida.
Mga Lungsod sa Florida
Opisyal na teksto ng pag-aaral (English)
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
- University of Florida, Gainesville
- Nemours Jacksonville, Jacksonville
- University of Miami, Miami
- at 2 pa
Nagre-recruitPhase 1
Edad 1 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07194044Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Johns Hopkins All Children's Hospital ( Site 1025), St. Petersburg
Nagre-recruitPhase 1/2
6 Months – 25 Years · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06395103Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- University of Florida, Gainesville
- Nicklaus Children's Hospital, Miami
- Arnold Palmer Hospital for Children, Orlando
- at 2 pa
Nagre-recruitPhase 1/2
Hanggang edad 30 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06541262Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- University of Florida, Gainesville
- Nicklaus Children's Hospital, Miami
- Arnold Palmer Hospital for Children, Orlando
- at 1 pa
Nagre-recruitPhase 1/2
Hanggang edad 26 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06465199Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
- St. Joseph's Children's Hospital, Tampa
Nagre-recruitPhase 2
Edad 0 hanggang 50 · Lahat ng kasarian · Na-update Hul 9, 2026 · NCT07321912Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
- University of Florida, Gainesville
Nagre-recruitPhase 1/2
6 Months – 25 Years · Lahat ng kasarian · Na-update Hun 30, 2026 · NCT06625190Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Johns Hopkins All Children's Hospital, St. Petersburg
Nagre-recruitPhase 1/2
Edad 2 hanggang 30 · Lahat ng kasarian · Na-update Peb 3, 2026 · NCT05734066Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.